Ochsner Health System Clinical Trials
Sponsors / Ochsner Health System
ClinicalTrials.gov lists 36 trials for which Ochsner Health System is named as lead sponsor. Of these, 2 are recruiting, 0 are active without new recruitment, and 18 have completed. The registry records 7 terminated or withdrawn trials for Ochsner Health System. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Planned participant enrollment across these trials sums to 2,908. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
36
Total Trials
2
Recruiting
0
Other Active
18
Completed
7
Terminated / Withdrawn
2,908
Total Enrollment
Termination reasons: Other43% · Recruitment29% · Efficacy14% · Regulatory14%
Recent Terminations
- Cirrhosis, Liver"Unable to recruit participants"
- NCT03916588 Stopped Dec 2020Dementia"covid"
- Adolescent Idiopathic Scoliosis"Device is no longer investigational. It has been approved by the FDA as an HUD under HDE H190005."
- End-stage Renal Disease"Results from futility analysis conducted at planned interim time-point did not meet the study criteria for continuation."
- Benign Intracranial Hypertension"Disparate corneal thickness readings from two measurement techniques employed."
- NCT02228538 Stopped Sep 2016Osteoarthritis of the Knee"Not enough subject participation"
- Otitis Media"Difficulty enrolling patients"
Active Trials (0 total)
- NCT07226973
- NCT06920563